Unknown

Dataset Information

0

The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.


ABSTRACT: HIV-infected individuals have an increased risk of cardiovascular disease (CVD). T-allele carriers of the CD14 C-260T single-nucleotide polymorphism (SNP) have reported increased expression of the LPS-binding receptor, CD14 and inflammation in the general population. Our aim was to explore the relationship of this SNP with monocyte/macrophage activation and inflammation and its association with sub-clinical atherosclerosis in HIV-infected individuals.Patients with no pre-existing CVD risk factors on suppressive antiretroviral therapy were recruited from University Malaya Medical Centre, Malaysia (n?=?84). The CD14 C-260T and TLR4 SNPs, Asp299Gly and Thr399Ile were genotyped and soluble(s) CD14 and sCD163 and high-sensitivity C-reactive protein, hsCRP were measured in plasma. Subclinical atherosclerosis was assessed by measuring carotid intima media thickness (cIMT). The association between CD14 C-260T SNP carriage and cIMT was assessed in a multivariable quantile regression model where a p-value of <0.05 was considered significant.We found the CD14 C-260T T-allele in 56% of the cohort and evidence of subclinical atherosclerosis in 27%. TT genotype was associated with higher sCD163 (p?=?0.009) but only marginally higher sCD14 (p?=?0.209) and no difference in hsCRP (p?=?0.296) compared to CC/CT. In multivariable analysis, only Framingham risk score was independently associated with higher cIMT while lower sCD163 was trending towards significance. No association was found in TT-genotype carriers and cIMT measurements.The CD14 C-260T SNP was associated with increased monocyte activation but not systemic inflammation or cIMT in this HIV-infected cohort with low CVD risk profile.

SUBMITTER: Rajasuriar R 

PROVIDER: S-EPMC4311493 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.

Rajasuriar Reena R   Kong Yong Yean YY   Nadarajah Reshika R   Abdullah Noor Kamila NK   Spelman Tim T   Yuhana Muhamad Yazli MY   Ponampalavanar Sasheela S   Kamarulzaman Adeeba A   Lewin Sharon R SR  

Journal of translational medicine 20150127


<h4>Background</h4>HIV-infected individuals have an increased risk of cardiovascular disease (CVD). T-allele carriers of the CD14 C-260T single-nucleotide polymorphism (SNP) have reported increased expression of the LPS-binding receptor, CD14 and inflammation in the general population. Our aim was to explore the relationship of this SNP with monocyte/macrophage activation and inflammation and its association with sub-clinical atherosclerosis in HIV-infected individuals.<h4>Methods</h4>Patients w  ...[more]

Similar Datasets

| 2135070 | ecrin-mdr-crc
| S-EPMC8943788 | biostudies-literature
| S-EPMC3916134 | biostudies-literature
| S-EPMC9964254 | biostudies-literature
| S-EPMC8615002 | biostudies-literature
| S-EPMC4983672 | biostudies-literature
2016-12-15 | GSE91072 | GEO
| S-EPMC1993545 | biostudies-literature
| S-EPMC4287849 | biostudies-literature
| S-EPMC3984082 | biostudies-literature